Stephanie Palmeri

Stephanie Palmeri invests as a Partner at NextView Ventures and runs personal angel activity from San Francisco, writing $100k-$250k checks at pre-seed and seed in digital health and AI/ML in healthcare. Her positioning is most useful for consumer-adjacent and SMB-targeted digital health companies, areas where NextView has historically been comfortable and where her own pattern recognition is strongest. The check range is meaningful enough to anchor a small pre-seed or fill out a seed alongside an institutional lead, and the AI focus suggests she’s actively evaluating LLM-enabled healthcare workflows and consumer health products rather than legacy SaaS. Founders building D2C health, telehealth-adjacent platforms, AI tools for healthcare consumers, or workflow software targeting smaller provider organizations should treat her as a credible early target. She is unlikely to be the right partner for biotech, devices, or pure life sciences plays. Outreach via LinkedIn with a sharp one-paragraph framing should work, and citing a specific NextView portfolio company that informs your thinking will strengthen the cold approach. With no public thesis statement attached to this profile, founders should rely on her NextView portfolio as a signal of taste and prioritize warm introductions through that network where possible. She is a credible early-stage partner for software-led healthcare companies but not a fit for capital-intensive science.